| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/18/2005 | WO2005059135A3 Treatment of mammals by sirna delivery into mammalian nerve cells |
| 08/18/2005 | WO2005058369A3 Compositions of l-caldesmon for treating viral infection |
| 08/18/2005 | WO2005052122A3 METHODS FOR CONTROLLING PATHOLOGICAL ANGIOGENESIS BY INHIBITION OF α6β4 INTEGRIN |
| 08/18/2005 | WO2005037323A3 Use of gro to treat or prevent inflammation |
| 08/18/2005 | WO2005037217A3 Lentiviral vector delivery of msp36 for treatment of cancer |
| 08/18/2005 | WO2005018549A3 Methods and compositions for tissue repair |
| 08/18/2005 | WO2004066946A3 Method for evaluating the efficacy of certain cancer treatments |
| 08/18/2005 | WO2004028458A3 Antisense modulation of microsomal prostaglandin e2 synthase expression |
| 08/18/2005 | WO2004011595A3 Vectors for transferring molecules of interest in target cells |
| 08/18/2005 | WO2002099049A3 Tbc1d1s as modifiers of the p53 pathway and methods of use |
| 08/18/2005 | US20050183146 Inhibitors of the inositol polyphosphate 5-phosphatase SHIP2 molecule |
| 08/18/2005 | US20050182418 Devices and methods for the restoration of a spinal disc |
| 08/18/2005 | US20050182249 Nucleotide sequences coding tumor suppressor protein for use in diagnosis, prevention and treatment of cancer; antitumor agents |
| 08/18/2005 | US20050182244 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 08/18/2005 | US20050182017 Immunostimulatory nucleic acid molecules |
| 08/18/2005 | US20050182016 promoter, the basal transcription regulatory region, and the transcription factor binding sites which are located upstream of, and are operatively linked to, the CRMP-1 gene; transfected cells |
| 08/18/2005 | US20050182014 Reducing arthritis and lameness in subjects by growth hormone releasing hormone (GHRH) supplementation |
| 08/18/2005 | US20050182013 mixing oligonucleotide and a polymer to form complex wherein zeta potential of complex is not positive, inserting oligonucleotide into mammalian blood vessel in vivo, increasing permeability of blood vessel, passing complex through vessel |
| 08/18/2005 | US20050182012 NF-kappaB oligonucleotide decoy molecules |
| 08/18/2005 | US20050182011 Use inhibitors of Transient Receptor Potential (TRP) channels to block non-voltage gated calcium flux into cells |
| 08/18/2005 | US20050182010 Use of a nucleotide construct stably integrated in the genome of the target cells of the virus, which is able to produce a single transcript or multiple transcripts capable of forming a double-stranded RNA which inhibits replication of the virus |
| 08/18/2005 | US20050182005 Anti-microRNA oligonucleotide molecules |
| 08/18/2005 | US20050182004 Modulation of DC-SIGN expression |
| 08/18/2005 | US20050182003 Drugs to be used in gene therapy for recessively transmitted genetic disease |
| 08/18/2005 | US20050181979 Vascular endothelial growth factor-2 |
| 08/18/2005 | US20050181507 Gene delivery vectors with cell type specificity for mesenchymal stem cells |
| 08/18/2005 | US20050181506 Chromosome-based platforms |
| 08/18/2005 | US20050181502 Multipotent adult stem cells and methods for isolation |
| 08/18/2005 | US20050181442 HCaRG, a novel calcium-regulated gene coding for a nuclear protein |
| 08/18/2005 | US20050181439 Streptococcus pneumoniae antigens and vaccines |
| 08/18/2005 | US20050181428 Expression vector comprising a ubiquitous chromatin opening element; CpG-island and tissue specific promoters for use in reproducible expression of heterologous gene sequences |
| 08/18/2005 | US20050181422 Process for high throughput screening of CpG-based immuno-agonist/antagonist |
| 08/18/2005 | US20050181418 Using nuclear protein (AM-1) as screening tool in diagnosing metastatic cancer |
| 08/18/2005 | US20050181391 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 08/18/2005 | US20050181382 Mediates silencing of a target gene; lessening the base pair strength between the 5' end of the first strand and the 3' end of a second strand of the duplex as compared to the base pair strength |
| 08/18/2005 | US20050181374 Kruppel-like factor 6 ( KLF6), a tumor suppressor protein, and diagnostics, therapeutics, and screening based on this protein |
| 08/18/2005 | US20050181368 Protein for use in hypoxia related conditions |
| 08/18/2005 | US20050181064 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith |
| 08/18/2005 | US20050181059 Mixing a nonsolvent (tert-butyl alcohol) that is miscible with water with the aqueous solution and precipitating particles of the biologically active agents out of the nonsolvent |
| 08/18/2005 | US20050181037 Cardiolipin compositions their methods of preparation and use |
| 08/18/2005 | US20050180981 Human checkpoint kinase, hCDS1, compositions and methods |
| 08/18/2005 | US20050180980 Novel antibody recognizing a small subset of human hematopoietic cells |
| 08/18/2005 | US20050180973 TREM-1 splice variant for use in modifying immune responses |
| 08/18/2005 | US20050180971 Cancer therapy |
| 08/18/2005 | US20050180960 producer cell (encapsulated in a matrix containing immunostimulating alginates) expresses a molecule that is an inhibitor of the growth of a CNS tumor |
| 08/18/2005 | US20050180959 Kinases involved in the regulation of energy homeostasis |
| 08/18/2005 | US20050180955 gene therapy; delivering recombinant adeno-associated virus virions to the brain; pumping; transgene encodes an aromatic amino acid decarboxylase |
| 08/18/2005 | US20050180951 Fusion of autologous dendrtic cells with cancer cells that have the same class I MHC haplotype as said patient; and interleukin-12 |
| 08/18/2005 | US20050180949 hC1Q/TNF7 and uses thereof |
| 08/18/2005 | US20050180947 Novel application of vaccination against TNF-alpha |
| 08/18/2005 | DE102004004894A1 Identifying substances that regulate PIM kinases, useful for treatment and diagnosis of urinary incontinence and the urge to urinate, and similar use of PIM proteins or nucleic acids |
| 08/18/2005 | CA2554632A1 Method of treating hemolytic disease |
| 08/18/2005 | CA2553886A1 Combined use of prame inhibitors and hdac inhibitors |
| 08/17/2005 | EP1564293A1 Neural thread protein gene expression and detection of Alzheimer's disease |
| 08/17/2005 | EP1564292A1 Pharmaceutical compositions and methods of treatment based on VEGF antisense oligonucleotides |
| 08/17/2005 | EP1563834A1 Hollow nanoparticles of protein and drug using the same |
| 08/17/2005 | EP1563092A2 Assays and methods based on microcompetition with a foreign polynucleotide |
| 08/17/2005 | EP1563070A2 2'-substituted oligomeric compounds and compositions for use in gene modulations |
| 08/17/2005 | EP1563069A2 Compositions and systems for the regulation of genes |
| 08/17/2005 | EP1563059A1 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders |
| 08/17/2005 | EP1563058A1 Hemangioblast progenitor cells |
| 08/17/2005 | EP1563056A2 Composition and method for treating lupus nephritis |
| 08/17/2005 | EP1562977A2 Active specific immunotherapy of cancer metastasis |
| 08/17/2005 | EP1562971A2 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 08/17/2005 | EP1562636A2 Mesenchymal stem cells and methods of use thereof |
| 08/17/2005 | EP1282639B1 Polyamide nucleic acid derivatives, agents and methods for producing the same |
| 08/17/2005 | EP1109908B1 Methods for determining compounds for modulating the body weight |
| 08/17/2005 | EP1100878B8 Process for producing genetically modified cd34-negative adherently growing haematopoietic stem cells |
| 08/17/2005 | EP1051500B1 Diagnosis and treatment of aur1 and/or aur2 related disorders |
| 08/17/2005 | EP0984983B1 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and a kinase domain |
| 08/17/2005 | EP0939804B1 NEUTROKINE alpha |
| 08/17/2005 | CN1656231A Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection |
| 08/17/2005 | CN1656223A Bone generation by gene therapy |
| 08/17/2005 | CN1656222A Antisense iap nucleobase oligomers and uses thereof |
| 08/17/2005 | CN1656216A Tolerogenic antigen-presenting cells |
| 08/17/2005 | CN1656120A Immunological binding molecules inhibiting the syncytial fusion of trophoblast |
| 08/17/2005 | CN1656114A Novel pancortin-pablo protein interactions and methods of use thereof |
| 08/17/2005 | CN1655827A Novel use of adenoviruses and nucleic acids coding therefor |
| 08/17/2005 | CN1655826A Non-viral gene delivery system |
| 08/17/2005 | CN1655825A Non-viral gene delivery system |
| 08/17/2005 | CN1655804A Method and composition for treating cardiovascular diseases by employing neuroregulation protein |
| 08/17/2005 | CN1655802A Bioadhesive directed somatic cell therapy |
| 08/17/2005 | CN1655798A Mixed-cell gene therapy |
| 08/17/2005 | CN1655775A Use of 20-HETE synthesizing enzyme inhibitors as therapy for cerebral vascular disease |
| 08/17/2005 | CN1654667A Attenuated HSV-1 vector for gene therapy |
| 08/17/2005 | CN1654664A Recombinant eukaryon expression vector capable of simultaneously expressing two antisense bFGF and uses thereof |
| 08/17/2005 | CN1654074A Anti cancer gene medicinal composition, micromolecule interfere RNA and its screening method |
| 08/16/2005 | US6930174 CCR5 chemokine receptor-specific antibodies |
| 08/16/2005 | US6930094 Tissue factor for influencing blood vessel formation |
| 08/16/2005 | US6930084 Treating arthritis with TNF receptor releasing enzyme |
| 08/16/2005 | US6929950 For implanting/transfecting monodispersed silicon particles joined to DNA into target tissue, cell or the blood stream |
| 08/16/2005 | US6929946 Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells |
| 08/16/2005 | US6929941 Chimeric cell-targeting pathogenic organism and method of therapeutic use |
| 08/16/2005 | US6929930 Nucleotide sequences coding antigenic peptide for use in diagnosis of bacterial infections |
| 08/16/2005 | US6929916 Kits for use in the detection of preferential interactions between biopolymers |
| 08/16/2005 | US6929792 administering to a patient genetically modified dendritic cells which are to express on the cell surface, an E/L-selectin chimera that contains the transmembrane and intracellular domains of L-selectin and extracellular domain of E-selectin |
| 08/16/2005 | CA2224257C Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 08/16/2005 | CA2084075C The ciliary neurotrophic factor receptor |
| 08/11/2005 | WO2005073385A1 Composition and method for elevating gene transfer efficiency |
| 08/11/2005 | WO2005073384A2 Human soluble neuropilin-1 primary polyadenylation signal and uses thereof |